To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Effectiveness of botulinum toxin for patients with chronic lateral epicondylitis

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
March 2013

Effectiveness of botulinum toxin for patients with chronic lateral epicondylitis

Vol: 2| Issue: 2| Number:99| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Use of anatomic measurement to guide injection of botulinum toxin for the management of chronic lateral epicondylitis: a randomized controlled trial

CMAJ. 2010 May 18;182(8):768-73. Epub 2010 Apr 26

Contributing Authors:
R Espandar P Heidari MR Rasouli S Saadat M Farzan M Rostami S Yazdanian SM Mortazavi

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

48 patients with chronic refractory lateral epicondylitis, who had completed a course of physiotherapy and/or received corticosteroid injections, were randomized to receive placebo or botulinum toxin A at the distance of one-third the length of the forearm from the tip of the lateral epicondyle on the course of the posterior inter-osseus nerve. At the study end point of 16 weeks, injecting botulin...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue